国产卡托普利联合倍他乐克治疗原发性高血压疗效观察

Effect Study of Domestic-Produced Catopril Combinated Betaloc in Systemic Hypertension

目的探讨治疗高血压经济、有效的药物。方法选择90例原发性高血压患者分2组进行达标血压治疗4周。结果2组药物治疗4周后,平均收缩压、舒张压、心率均较服药前明显降低,差异均有非常显著性意义(P<0.01)。治疗组治疗后与对照组治疗后比较收缩压、舒张压、心率差异均无显著性意义(P>0.05),2组疗效间比较差异无显著性意义(χ2=0.05,P>0.05)。结论2组药物治疗高血压疗效无差异,国产卡托普利联合倍他乐克治疗原发性高血压,可以减少治疗成本,改善顺从性。

Objective To explore economic effectiven of Systemic hypertension medicine. Methods Ninty patients who were randomly divided into two groups and treated roaching the standard four weeks. Results After 4 weeks treatment, there were significant differences in lowering systolic blood pressure （ SBP）, diastolic blood pressure （DBP） and heart rate in the two groups （ P 〈0. 01 ）. Both drugs were treated systolic blood pressure （SBP）, diastolic blood pressure （DBP） and heart rate there are no significant difference （ P 〉 0. 05）. Two groups drugs were similarly effective （ x^2 = 0. 05, P 〉 0. 05 ）. Conclusion The effective power of two groups medicine in treat hypertension is similar domestic - product Catopril combinated with Betaloc to treat hypertension may reduce the treated cost and improve compliance.